Recent Advances in the Treatment of Genetic Forms of Parkinson’s Disease: Hype or Hope?
Parkinson’s disease (PD) is a multifarious neurodegenerative disease. Its pathology is characterized by a prominent early death of dopaminergic neurons in the pars compacta of the substantia nigra and the presence of Lewy bodies with aggregated α-synuclein. Although the α-synuclein pathological aggr...
Main Authors: | Francesco Cavallieri, Rubens G. Cury, Thiago Guimarães, Valentina Fioravanti, Sara Grisanti, Jessica Rossi, Edoardo Monfrini, Marialuisa Zedde, Alessio Di Fonzo, Franco Valzania, Elena Moro |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/12/5/764 |
Similar Items
-
Neurodegenerative models in Drosophila: Polyglutamine disorders, Parkinson disease, and amyotrophic lateral sclerosis
by: Surendra S. Ambegaokar, et al.
Published: (2010-10-01) -
Genotype-driven therapeutic developments in Parkinson’s disease
by: Jannik Prasuhn, et al.
Published: (2021-04-01) -
Molecular chaperones and Parkinson's disease
by: Shenglan Hu, et al.
Published: (2021-12-01) -
Neurosteroid Levels in GBA Mutated and Non-Mutated Parkinson’s Disease: A Possible Factor Influencing Clinical Phenotype?
by: Francesco Cavallieri, et al.
Published: (2024-08-01) -
Effects of Telmisartan, an AT1 receptor antagonist, on mitochondria-specific genes expression in a mouse MPTP model of Parkinsonism
by: Bipul Ray, et al.
Published: (2021-08-01)